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A B S T R A C T
Guidelines for blood culture (BC) address the appropriate frequency, number and volume, but no
guidelines exist for repeating BCs. The pattern of repeated BCs was studied in all patients hospitalised in
December 2001 to determine the extent of and reasons for repeating cultures. BC was repeated in 127
(31.6%) of 405 adults with an initial BC during the study period. All patients with available records
(n = 96; 75.6%) were included. The average patient age was 62.2 ± 15.9 years. In total, 295 BC sets (one
to four BCs ⁄ set) were obtained, comprising 96 initial and 199 repeats (one to nine repeats ⁄patient). Sixty-
nine (34.7%) repeats were taken within 24 h, and 89 (44.7%) within 2–4 days. The most common reason
(32.2%) was persistent fever. The result of repeated cultures was: no growth (83.4%), same pathogen
(9.1%), new pathogen (2.5%) or contamination (5.0%). Thus, BC repeats accounted for one-third of all
BCs handled in the laboratory, with little additional yield. Guidelines for repeating BCs may decrease
unnecessary testing.
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I N T R O D U C T I O N
Blood cultures (BCs) are important in the man-
agement of patients with infection. They may
provide important diagnostic and prognostic
indicators, as well as establishing a microbial
aetiology in cases of suspected infection [1–3].
With the known serious complications of unrec-
ognised bacteraemia and the potential conse-
quences, clinicians are likely to request BCs
frequently [4]. Additionally, when the patient
remains febrile, especially if critically ill, clini-
cians may opt for repeat BCs, although the value
of these repeats has been questioned [4–6].
Whatever the reason, substantial numbers of
BCs are now handled by microbiology laborat-
ories [4,5]. Assuming a constant rate of contam-
ination, the more BCs performed, the higher the
chance of encountering contamination, which
may result in increased costs, inappropriate use
of antibiotics and unnecessary consultations [5,6].
However, obtaining more BCs may increase the
diagnostic yield in some conditions, such as
endocarditis, or in patients with intermittent
bacteraemia.
Available guidelines for BC include informa-
tion on the indications, optimal number, appro-
priate interval and interpretation [7]. Generally,
BC is indicated in patients suspected to have
bacteraemia on the basis of the type of infection,
the clinical condition and host-related risk factors
[7]. However, no such guidelines exist for repeat-
ing BC. Numerous studies illustrate the lack of
value in repeating BC, especially after initiating
antibiotic therapy [8–10]. In order to generate
guidelines for repeating BC, the practice pattern
at our institution was studied.
M A T E R I A L S A N D M E T H O D S
A review of the records for all BCs obtained in December 2001
was performed. All patients with repeated testing (see defini-
tion below) were identified. A retrospective review of medical
records was conducted with a standardised data collection
form that included patient demographics, co-morbid condi-
tions, admitting service, type of admission (intensive care units
vs. general wards) and culture results. The reason for repeat-
ing BC was determined by reviewing physician and nursing
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progress notes, orders and laboratory results. Included were
adult inpatients aged ‡ 18 years with completed medical
records. Excluded were paediatric cases, those with incom-
plete medical records, and those who had repeat BC done
when they were outpatients.
Definitions
Bacteraemia
Isolation of a pathogenic organism from at least one BC, or the
isolation of a common contaminant (coagulase-negative sta-
phylococci, viridans streptococci, Bacillus spp. or Corynebacte-
rium spp.) from at least two BCs with clinical signs of infection
and a possible source.
Contamination
Isolation of a common contaminant from a single BC without
signs of infection; judged by the attending physician to be a
contaminant and no treatment initiated.
Mixed bacteraemia and ⁄ or contamination
Isolation of a pathogen and a common contaminant from one
BC.
BC group
A group of one or more BCs obtained in a 24-h period after a
single physician order. Phlebotomists were instructed to obtain
20 mL for each BC, with 10 mL inoculated into each aerobic
and anaerobic bottle (the actual volume was not recorded).
Initial BC
First group of BCs ordered.
BC repeat
Each additional group obtained after a separate physician
order.
Fever
Any temperature ‡ 38.5C, or two sequential readings of
‡ 38.0C.
Hypothermia
Any temperature £ 35C.
Persistent fever
Fever that continued daily without interruption or a single day
without a fever.
New fever
Fever occurring at least 2 days after resolution of a preceding
fever.
Leukocytosis
White blood cell count of > 11 · 103 cells ⁄mm3.
Leukopenia
White blood cell count of <3 · 103 cells ⁄mm3.
Haemodynamic changes
Systolic blood pressure £ 80 mmHg, or a > 40-mm drop in
baseline pressure with or without tachycardia.
Statistical methods
The significance of observed differences was assessed by the
chi-square test, utilising SPSS software release 10 (SPSS Inc.,
Chicago, IL, USA), with p < 0.05 considered to be significant.
R E S U L T S
In total, 1221 BCs were obtained from 471 inpa-
tients. These comprised a single BC in 110 (23.4%)
cases, and a group of two, three or four BCs in 344
(73.0%), 13 (2.8%) and four (0.8%) cases, respect-
ively. The BCs were positive in 160 (13.1%) cases,
of which 34 (2.8% of the total) were thought to
represent contamination. Paediatric cases accoun-
ted for 66 patients. Among the 405 adult patients,
127 (31.6%) had BC repeats, of whom 96 met the
inclusion criteria.
The average age of the study group was
62.2 ± 15.9 years (range 18–89 years), 50% were
female, and 42.7% of the patients had one or more
co-morbid conditions. Fifty-six (58.3%) patients
were either admitted to an intensive care unit
(n = 50) or eventually transferred to the unit
(n = 6). The admitting services were medicine
(n = 73; 76.0%), surgical specialties (21; 21.9%),
and family practice (2; 2.1%).
Among the 96 patients, BC was repeated in 199
instances, with an average of 3.1 ± 1.5 repeats ⁄
patient (range 1–9; median 3). The repeats were
obtained within 0–23 days, with a median of
2 days. Nineteen (9.5%) repeats were obtained on
the same day (six before initiating antibiotics),
and 50 (25.1%) on the following day; most
(n = 158; 79.4%) were obtained within 4 days.
They were obtained as a single BC in 42 instances
(21.1%), as a group of two in 156 (78.4%)
instances, and as a group of three in one (0.5%)
instance. Most repeats (n = 158; 79.4%) were
obtained while patients were receiving antibiotics,
including 73 (90.1%) of 81 repeats among patients
with an initial positive BC (of whom 69 (94.5%)
were receiving adequate antimicrobial coverage
for the initial isolate).
The most common reasons for repeating BC
were persistent fever and follow-up of a positive
BC (Table 1). The frequency of repeat BC was
comparable in the general wards and the inten-
sive care units (2.2 ± 1.7 vs. 2.0 ± 1.3, respect-
ively); however, BC was repeated more often
because of new or persistent leukocytosis in the
intensive care unit (19.4% vs. 11.0%), and on
Table 1. Reason for repeating blood culture and the
results of repeats
Reason (n)
Repeat culture result: n (%)
Same
pathogen
New
pathogen Contamination Negative
Persistent fever (64) 4 (6.3) 1 (1.5) 3 (4.7) 56 (87.5)
Follow-up of positive BC (38) 8 (21.1) 0 1 (2.6) 29 (76.3)
New fever (34) 1 (2.9) 1 (2.9) 2 (5.9) 30 (88.2)
Leukocytosis (28) 3 (10.7) 0 2 (7.1) 23 (82.2)
Haemodynamic changes (9) 1 (11.1) 1 (11.1) 1 (11.1) 6 (66.7)
Focus of infection (6) 0 0 0 6 (100)
Undetermined (20) 1 (5.0) 2 (10.0) 1 (5.0) 16 (80.0)
All cases (199) 18 (9.1) 5 (2.5) 10 (5.0) 166 (83.4)
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surgical services (17.5% vs. 13.2%). The same
pathogen was identified in 18 repeats, and a new
pathogen was identified in five repeats. No
significant difference was noted according to the
patient’s antibiotic status (Table 2).
Analysis of the yield of repeats according to the
results of the initial BC (Table 3) showed that
patients with true bacteraemia were more likely
to have positive repeats. Most positive repeats
yielded the same pathogen, especially for patients
with Staphylococcus aureus bacteraemia. In con-
trast, among patients with contamination or an
initial negative BC, repeats showed true bacter-
aemia in only two (1.7%) instances. This differ-
ence was statistically significant (p 0.001).
D I S C U S S I O N
Guidelines for obtaining BCs and inter-
preting culture results exist to maximise the yield,
differentiate contaminants and optimise the num-
ber of tests [2,3]. Generally, three determinants
may affect the yield of BC: bacterial concentration
in the blood; the volume of blood drawn for
culture; and the rate of contamination [6,11]. The
trend in the newer recommendations is toward
fewer cultures (which minimises the problem of
contamination), a larger volume of blood (which
increases the yield), and reliance on clinical
assessment to distinguish contamination rather
than repeating cultures [12]. Once initial cultures
are obtained, the value of additional cultures
appears questionable. Several studies have shown
that repeat BCs are superfluous [4–6]. Exceptions
may be patients with suspected endocarditis who
were receiving antibiotics at the time of initial
culture or shortly before [10]. Yet, BCs are often
repeated [4,5]. Possible factors that prompt clini-
cians to repeat cultures include a new septic
episode, persistent fever and leukocytosis.
The present study investigated the pattern of
repeat BCs at our institution in order to determine
whether guidelines were needed to regulate this
practice. The frequency of repeat culture and the
possible triggers were investigated. The findings
showed that repeat BCs accounted for one-third
of the BCs handled in the microbiology laborat-
ory. Extrapolating from the data obtained for
1 month, the estimated number of repeated BCs
in the laboratory was c. 5668 ⁄ year. The usual
triggers included persistent fever and leukocyto-
sis. Leukocytosis was often a trigger in the
intensive care unit and on surgical services,
probably reflecting the incidence of leukocytosis
in post-operative or critically ill patients. Altera-
tions in the patient’s condition suggestive of a
new septic episode, such as haemodynamic chan-
ges consistent with sepsis, were noted in a
minority of cases. No difference was detected in
the yield of repeat BCs based on a patient’s
antibiotic status, probably because of inadequate
sample size for meaningful assessment.
Analysis of repeated culture results according
to the initial BC showed that patients with
contaminants or an initial negative culture were
very unlikely to have positive repeats. Moreover,
most patients with positive repeats had the same
pathogen isolated.
A limitation of this study was the possibility of
other triggers for culture that could not be
identified because of the retrospective nature of
the investigation. For instance, repeat BCs may
be ordered when physicians are contacted by the
nursing staff because of persistent fever or
following laboratory test results. Additionally,
when multiple services or physicians participate
in patient care, some may order cultures, una-
ware that BC has already been performed.
However, the findings illustrate that guidelines
for repeat culturing are needed.
Table 2. Results of repeated blood culture according to the
time of repeat and antibiotic status
Time of repeat
Antibiotic
status (n)
Repeat culture result: n (%)
Same
pathogen
New
pathogen Contaminant Negative
Same day Present (14) 0 1 (7.1) 1 (7.1) 12 (85.8)
Absent (5) 1 (20.0) 0 0 4 (80.0)
Following day Present (42) 9 (21.4) 2 (4.8) 0 31 (73.8)
Absent (8) 0 1 (12.5) 0 7 (87.5)
2–4 days Present (73) 7 (9.6) 0 5 (6.8) 61 (83.6)
Absent (16) 0 0 1 (6.2) 15 (93.8)
‡ 5 days Present (29) 1 (3.4) 1 (3.4) 2 (6.9) 25 (86.2)
Absent (12) 0 0 1 (8.3) 11 (92.7)
All cases Present (158) 17 (10.8) 4 (2.5) 8 (5.1) 129 (81.6)
Absent (41) 1 (2.4) 1 (2.4) 2 (4.9) 37 (90.3)
Table 3. Analysis of the results of repeated blood cultures
according to the results of initial culture
Result of repeat
culture
Results of initial BC (number of repeated BCs): n (%)
True bacteraemia
(81)
Contaminant
(14)
Negative
(104)
Same pathogen 18 (22.2)a 0 0
New pathogen 3 (3.7) 1 (7.1) 1 (1.0)
Contaminant 3 (3.7) 1 (7.1) 6 (5.8)
Negative 57 (70.4) 12 (85.2) 97 (93.2)
aStaphylococcus aureus (n = 12), Enterococcus faecalis (n = 3), Staphylococcus lugdunen-
sis (n = 1), Klebsiella pneumoniae (n = 1), Corynebacterium species (n = 1).
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Until a consensus is reached and validated, it is
suggested that repeat BCs may be appropriate in
the following circumstances:
1. New septic episode. A standardised definition
of a new septic episode is necessary, perhaps
based on a new fever, a change in fever
pattern, or new haemodynamic changes con-
sistent with sepsis.
2. Suspected endocarditis when initial cultures
were obtained during the period of suppres-
sion secondary to recent use of antibiotics.
3. Follow-up of a positive BC in certain condi-
tions that may have diagnostic and therapeutic
implications, such as S. aureus bactaeremia,
where the length of therapy may be deter-
mined by the duration of bacteraemia [13–15],
candidaemia, and bacteraemia caused by
Gram-negative bacilli.
4. Confirmation of response to therapy for endo-
carditis or other endovascular infections
caused by S. aureus, Enterococcus spp., Gram-
negative bacilli or other difficult-to-treat organ-
isms. In some of these cases, the use of clinical
data may not be reliable because bacteraemia
may persist without systemic manifestations
during therapy.
5. Confirmation of diagnosis of intravascular
catheter-associated bacteraemia, in some cases
by obtaining BCs from the line and a periph-
eral site before initiating antibiotics.
Repeat BCs appear to be superfluous in the
following circumstances:
1. Persistent fever without new findings.
2. New fever that could be accounted for by a
non-infectious aetiology.
3. Leukocytosis without other clinical findings
suggestive of new sepsis. Although leukocyto-
sis is listed as an indication for BC in some
guidelines [1], the predictive value without
other signs or symptoms has not been valid-
ated, especially in nosocomial settings and
post-operative patients [16,17].
4. Colonisation or focal infection without sys-
temic signs or symptoms.
These proposed guidelines require further val-
idation and discussion, and may not apply to
certain patient populations, such as immunocom-
promised subjects, and especially those with
neutropenia.
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